Company · CIK 0000704562 · SIC 2834 — Pharmaceutical Preparations
Avid Bioservices, Inc. · CDMO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2018 SForm 4 → | Sep 21, 6:22 pm EDT | Joel McCombDirector | 50,000 | $6.53 | $326,286 | 0 | −100% | plan? |
| Feb 15, 2018 PForm 4 → | Feb 20, 6:15 pm EST | Joel McCombDirector | 50,000 | $2.25 | $112,500 | 50,000 | — | plan? |
| Feb 15, 2018 PForm 4 → | Feb 20, 6:14 pm EST | Joseph CarleoneDirector | 44,445 | $2.25 | $100,001 | 44,445 | — | plan? |
| Feb 15, 2018 PForm 4 → | Feb 20, 6:13 pm EST | Mark R BamforthDirector | 50,000 | $2.25 | $112,500 | 100,000 | +100% | plan? |
| Oct 31, 2017 JForm 4 → | Nov 1, 3:13 pm EDT | Joseph ShanVP, Clinical and Reg Affairs | 2,747 | $3.87 | $10,624 | 16,187 | — | plan? |
| Oct 31, 2017 JForm 4 → | Nov 1, 3:12 pm EDT | Steven W KingPresident & CEO, Director | 1,398 | $3.87 | $5,407 | 34,646 | — | plan? |
| Oct 27, 2017 PForm 4 → | Oct 27, 6:15 pm EDT | Mark R BamforthDirector | 50,000 | $4.50 | $225,091 | 50,000 | — | plan? |
| Apr 28, 2017 JForm 4 → | Apr 28, 6:58 pm EDT | Joseph ShanVP, Clinical and Reg Affairs | 39,177 | $0.2712 | $10,625 | 94,079 | — | plan? |
| Apr 28, 2017 JForm 4 → | Apr 28, 6:57 pm EDT | Paul J LytleChief Financial Officer | 37,389 | $0.2712 | $10,140 | 184,038 | — | plan? |
| Apr 28, 2017 JForm 4 → | Apr 28, 6:56 pm EDT | Steven W KingPresident & CEO, Director | 19,941 | $0.2712 | $5,408 | 232,730 | — | plan? |
| Oct 31, 2016 JForm 4 → | Nov 1, 8:06 pm EDT | Joseph ShanVP, Clinical and Reg Affairs | 33,783 | $0.2864 | $9,675 | 54,902 | — | plan? |
| Oct 31, 2016 JForm 4 → | Nov 1, 8:04 pm EDT | Paul J LytleChief Financial Officer | 33,783 | $0.2864 | $9,675 | 146,649 | — | plan? |
| Oct 31, 2016 JForm 4 → | Nov 1, 8:02 pm EDT | Steven W KingPresident & CEO, Director | 18,826 | $0.2864 | $5,392 | 212,789 | — | plan? |
| Oct 31, 2016 JForm 4 → | Nov 1, 7:58 pm EDT | Shelley PM FusseyV.P., Intellectual Property | 25,433 | $0.2864 | $7,284 | 135,908 | — | plan? |
| Apr 29, 2016 JForm 4 → | May 2, 8:19 pm EDT | Joseph ShanVP, Clinical and Reg Affairs | 10,683 | $0.301 | $3,216 | 21,119 | — | plan? |
| Apr 29, 2016 JForm 4 → | May 2, 8:19 pm EDT | Steven W KingPresident & CEO, Director | 10,683 | $0.301 | $3,216 | 193,963 | — | plan? |
| Apr 29, 2016 JForm 4 → | May 2, 8:18 pm EDT | Shelley PM FusseyV.P., Intellectual Property | 10,683 | $0.301 | $3,216 | 110,475 | — | plan? |
| Oct 30, 2015 JForm 4 → | Nov 2, 4:17 pm EST | Paul J LytleChief Financial Officer | 6,158 | $0.95 | $5,850 | 112,866 | — | plan? |
| Oct 30, 2015 JForm 4 → | Nov 2, 4:16 pm EST | Steven W KingPresident & CEO, Director | 5,474 | $0.95 | $5,200 | 183,280 | — | plan? |
| Oct 30, 2015 JForm 4 → | Nov 2, 4:16 pm EST | Shelley PM FusseyV.P., Intellectual Property | 8,448 | $0.95 | $8,026 | 99,792 | — | plan? |
| Apr 30, 2015 JForm 4 → | May 1, 12:57 pm EDT | Paul J LytleChief Financial Officer | 5,217 | $1.11 | $5,791 | 106,708 | — | plan? |
| Apr 30, 2015 JForm 4 → | May 1, 12:57 pm EDT | Steven W KingPresident & CEO, Director | 4,634 | $1.11 | $5,144 | 177,806 | — | plan? |
| Apr 30, 2015 JForm 4 → | May 1, 12:56 pm EDT | Shelley PM FusseyV.P., Intellectual Property | 7,179 | $1.11 | $7,969 | 91,344 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2018 AForm 4 → | Dec 18, 8:26 pm EST | Patrick D WalshDirector | 19,600 | — | — | 94,600 | — | |
| Dec 14, 2018 AForm 4 → | Dec 18, 8:24 pm EST | Gregory SargenDirector | 19,600 | — | — | 94,600 | — | |
| Dec 14, 2018 AForm 4 → | Dec 18, 8:22 pm EST | Joel McCombDirector | 19,600 | — | — | 94,600 | — | |
| Dec 14, 2018 AForm 4 → | Dec 18, 8:19 pm EST | Richard B HancockDirector | 19,600 | — | — | 94,600 | — | |
| Dec 14, 2018 AForm 4 → | Dec 18, 8:17 pm EST | Joseph CarleoneDirector | 19,600 | — | — | 94,600 | — | |
| Dec 14, 2018 AForm 4 → | Dec 18, 8:16 pm EST | Mark R BamforthDirector | 19,600 | — | — | 94,600 | — | |
| Aug 1, 2018 AForm 4 → | Aug 3, 6:49 pm EDT | Daniel Ryan HartChief Financial Officer | 107,000 | — | — | 0 | — | |
| May 1, 2018 AForm 4 → | May 3, 8:03 pm EDT | Roger J. LiasPresident & CEO, Director | 50,000 | — | — | 200,000 | — | |
| Nov 27, 2017 AForm 4 → | Nov 29, 8:08 pm EST | Gregory SargenDirector | 75,000 | — | — | 75,000 | — | |
| Nov 27, 2017 AForm 4 → | Nov 29, 8:07 pm EST | Joel McCombDirector | 75,000 | — | — | 75,000 | — | |
| Nov 27, 2017 AForm 4 → | Nov 29, 8:06 pm EST | Richard B HancockDirector | 75,000 | — | — | 75,000 | — | |
| Nov 27, 2017 AForm 4 → | Nov 29, 8:05 pm EST | Joseph CarleoneDirector | 75,000 | — | — | 75,000 | — | |
| Oct 20, 2017 AForm 4 → | Oct 24, 5:23 pm EDT | Patrick D WalshDirector | 75,000 | — | — | 75,000 | — | |
| Oct 17, 2017 AForm 4 → | Oct 24, 5:22 pm EDT | Mark R BamforthDirector | 75,000 | — | — | 75,000 | — | late |
| Sep 25, 2017 AForm 4 → | Sep 27, 6:48 pm EDT | Roger J. LiasPresident ***, Director | 150,000 | — | — | 150,000 | — | |
| Aug 25, 2017 JForm 4 → | Aug 29, 5:16 pm EDT | Eric S SwartzDirector | 20,672 | — | — | 253,541 | — | |
| Aug 25, 2017 JForm 4 → | Aug 29, 5:16 pm EDT | David PohlDirector | 11,908 | — | — | 262,305 | — | |
| Aug 25, 2017 JForm 4 → | Aug 29, 5:15 pm EDT | Carlton M JohnsonDirector | 34,958 | — | — | 239,255 | — | |
| Jun 2, 2016 AForm 4 → | Jun 3, 8:38 pm EDT | Mark R ZiebellVP and General Counsel | 150,000 | — | — | 975,000 | — | |
| Jun 2, 2016 AForm 4 → | Jun 3, 7:55 pm EDT | Eric S SwartzDirector | 200,000 | — | — | 1,919,500 | — | |
| Jun 2, 2016 AForm 4 → | Jun 3, 7:54 pm EDT | Joseph ShanVP, Clinical and Reg Affairs | 150,000 | — | — | 1,035,000 | — | |
| Jun 2, 2016 AForm 4 → | Jun 3, 7:54 pm EDT | David PohlDirector | 200,000 | — | — | 1,919,500 | — | |
| Jun 2, 2016 AForm 4 → | Jun 3, 7:53 pm EDT | Paul J LytleChief Financial Officer | 250,000 | — | — | 1,547,500 | — | |
| Jun 2, 2016 AForm 4 → | Jun 3, 7:52 pm EDT | Steven W KingPresident & CEO, Director | 500,000 | — | — | 2,976,137 | — | |
| Jun 2, 2016 AForm 4 → | Jun 3, 7:52 pm EDT | Carlton M JohnsonDirector | 200,000 | — | — | 1,919,500 | — | |
| Jun 2, 2016 AForm 4 → | Jun 3, 7:51 pm EDT | Shelley PM FusseyV.P., Intellectual Property | 150,000 | — | — | 893,000 | — | |
| May 23, 2016 PForm 4 → | May 24, 7:44 pm EDT | Mark R ZiebellV. P., General Counsel | 900 | $12.13 | $10,920 | 900 | — | |
| May 11, 2015 AForm 4 → | May 12, 8:08 pm EDT | Mark R ZiebellV.P., General Counsel | 100,000 | — | — | 825,000 | — | |
| May 11, 2015 AForm 4 → | May 12, 8:07 pm EDT | Eric S SwartzDirector | 187,500 | — | — | 1,719,500 | — | |
| May 11, 2015 AForm 4 → | May 12, 8:06 pm EDT | Joseph ShanVP, Clinical and Reg Affairs | 100,000 | — | — | 885,000 | — | |
| May 11, 2015 AForm 4 → | May 12, 8:06 pm EDT | David PohlDirector | 187,500 | — | — | 1,719,500 | — | |
| May 11, 2015 AForm 4 → | May 12, 8:05 pm EDT | Paul J LytleChief Financial Officer | 150,000 | — | — | 1,297,500 | — | |
| May 11, 2015 AForm 4 → | May 12, 8:04 pm EDT | Steven W KingPresident & CEO, Director | 300,000 | — | — | 2,476,137 | — | |
| May 11, 2015 AForm 4 → | May 12, 8:03 pm EDT | Carlton M JohnsonDirector | 187,500 | — | — | 1,719,500 | — | |
| May 11, 2015 AForm 4 → | May 12, 8:02 pm EDT | Shelley PM FusseyV.P., Intellectual Property | 75,000 | — | — | 743,000 | — |